These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3580964)

  • 21. Speciation of elements in biological, environmental and toxicological sciences: Report on the Fourth International Symposium on the 'Speciation of Elements in Biological, Environmental and Toxicological Sciences' (Whistler, British Columbia, Canada, June 25-July 1, 2000).
    Milacic R
    Environ Sci Pollut Res Int; 2000; 7(4):246. PubMed ID: 19005844
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanistic approaches to chemoprevention of mutation and cancer.
    Ferguson LR; Bronzetti G; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):3-7. PubMed ID: 16095634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer chemoprevention: a summary of the current evidence.
    Bonovas S; Tsantes A; Drosos T; Sitaras NM
    Anticancer Res; 2008; 28(3B):1857-66. PubMed ID: 18630472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
    Niles RM
    Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 Apr; 158(8):1033-5. PubMed ID: 9580732
    [No Abstract]   [Full Text] [Related]  

  • 28. Participation in high school physical education--Ontario, Canada, 1999-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jan; 56(3):52-4. PubMed ID: 17251898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer prevention: past, present, and future.
    Young RC; Wilson CM
    Clin Cancer Res; 2002 Jan; 8(1):11-6. PubMed ID: 11801534
    [No Abstract]   [Full Text] [Related]  

  • 30. 10th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Niagara-on-the-Lake, Ontario, Canada, June 6-7, 2008--State of the Art Series. Commentary.
    Green DM
    Pediatr Blood Cancer; 2009 Aug; 53(2):248. PubMed ID: 19343779
    [No Abstract]   [Full Text] [Related]  

  • 31. Radical causes of cancer.
    Hussain SP; Hofseth LJ; Harris CC
    Nat Rev Cancer; 2003 Apr; 3(4):276-85. PubMed ID: 12671666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailoring cancer chemoprevention regimens to the individual.
    Conney AH
    J Cell Biochem; 2004 Feb; 91(2):277-86. PubMed ID: 14743388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canadian contributions to cancer control.
    Miller AB
    Can J Oncol; 1994 Jan; 4(1):238-42. PubMed ID: 7512409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research advances in Alzheimer's disease and related neurodegenerative disorders. Proceedings of the First Canadian Symposium on the Organic Dementias. London, Ontario, June 23-24, 1986.
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):381-572. PubMed ID: 3791051
    [No Abstract]   [Full Text] [Related]  

  • 35. The NCIC/CCS behavioral initiative. National Cancer Institute of Canada Canadian Cancer Society.
    Iverson DC
    Can J Oncol; 1994 Apr; 4(2):255-61. PubMed ID: 8004409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nursing's role in shaping cancer control for the future: the Canadian Strategy for Cancer Control.
    Chapman K; Green E
    Can Oncol Nurs J; 2001; 11(4):203-5. PubMed ID: 11842453
    [No Abstract]   [Full Text] [Related]  

  • 37. Status report. Canadian association of provincial cancer agencies.
    Carlow DR
    Chronic Dis Can; 2000; 21(1):30-3. PubMed ID: 10813692
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
    Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
    Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers: from development to implementation. Proceedings of a symposium of the Canadian Federation of Biological Societies. Saskatoon, Saskatchewan, Canada, June 17, 1995.
    Can J Physiol Pharmacol; 1996 Feb; 74(2):125-222. PubMed ID: 9081770
    [No Abstract]   [Full Text] [Related]  

  • 40. Role and mechanisms of inhibitors in prevention of mutation and cancer.
    Mutat Res; 1988 Dec; 202(2):277-446. PubMed ID: 3193972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.